PLN 7.45
(-0.67%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 506 Thousand PLN | 145.63% |
2022 | 206 Thousand PLN | -46.91% |
2021 | 388 Thousand PLN | 10.54% |
2020 | 351 Thousand PLN | -31.08% |
2019 | 509.3 Thousand PLN | 240.87% |
2018 | 149.41 Thousand PLN | 17.65% |
2017 | 126.99 Thousand PLN | -42.11% |
2016 | 219.39 Thousand PLN | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 259 Thousand PLN | -14.24% |
2024 Q1 | 302 Thousand PLN | -40.32% |
2023 Q3 | 7000.00 PLN | 0.0% |
2023 Q4 | 506 Thousand PLN | 7128.57% |
2023 FY | 506 Thousand PLN | 145.63% |
2023 Q1 | 7000.00 PLN | -96.6% |
2023 Q2 | 7000.00 PLN | 0.0% |
2022 Q3 | 320 Thousand PLN | 2.89% |
2022 Q2 | 311 Thousand PLN | -9.33% |
2022 Q4 | 206 Thousand PLN | -35.63% |
2022 Q1 | 343 Thousand PLN | -11.6% |
2022 FY | 206 Thousand PLN | -46.91% |
2021 FY | 388 Thousand PLN | 10.54% |
2021 Q3 | 358 Thousand PLN | 0.56% |
2021 Q4 | 388 Thousand PLN | 8.38% |
2021 Q1 | 354 Thousand PLN | 0.85% |
2021 Q2 | 356 Thousand PLN | 0.56% |
2020 Q4 | 351 Thousand PLN | -8.5% |
2020 FY | 351 Thousand PLN | -31.08% |
2020 Q3 | 383.6 Thousand PLN | -25.69% |
2020 Q2 | 516.18 Thousand PLN | 0.67% |
2020 Q1 | 512.74 Thousand PLN | 0.68% |
2019 Q3 | 505.83 Thousand PLN | -35.55% |
2019 Q2 | 784.82 Thousand PLN | 421.06% |
2019 Q1 | 150.62 Thousand PLN | 0.81% |
2019 FY | 509.3 Thousand PLN | 240.87% |
2019 Q4 | 509.3 Thousand PLN | 0.69% |
2018 Q1 | - PLN | -100.0% |
2018 Q2 | 191.77 Thousand PLN | 0.0% |
2018 Q3 | 192.89 Thousand PLN | 0.58% |
2018 FY | 149.41 Thousand PLN | 17.65% |
2018 Q4 | 149.41 Thousand PLN | -22.54% |
2017 FY | 126.99 Thousand PLN | -42.11% |
2017 Q4 | 126.99 Thousand PLN | 0.0% |
2016 FY | 219.39 Thousand PLN | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Adiuvo Investments S.A. | 23.56 Million PLN | 97.852% |
Genomtec S.A. | 1.96 Million PLN | 74.197% |
Medicalgorithmics S.A. | 5.68 Million PLN | 91.104% |
Synektik Spólka Akcyjna | 18.85 Million PLN | 97.316% |